Keith Grossman, Chairman, Chief Executive Officer and President of Nevro, said: "This FDA approval marks another milestone in Nevro's commitment to expanding access to 10 kHz Therapy for these ...

REDWOOD CITY, Calif., Oct. 3, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...